Your browser doesn't support javascript.
loading
Potential Mechanisms of the Impact of Hepatocyte Growth Factor Gene-Modified Tendon Stem Cells on Tendon Healing.
Zhang, Mingzhao; Liu, Hengchen; Shi, Manyu; Zhang, Tingting; Lu, Wenjun; Yang, Shulong; Cui, Qingbo; Li, Zhaozhu.
Afiliação
  • Zhang M; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Liu H; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Shi M; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang T; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Lu W; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Yang S; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Cui Q; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li Z; Department of Pediatric Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Cell Dev Biol ; 9: 659389, 2021.
Article em En | MEDLINE | ID: mdl-34222233
ABSTRACT
The therapeutic impact of stem cells is potentially largely attributable to secretion of exosomes and soluble factors. The present study evaluates the impact of hepatocyte growth factor (HGF)-expressing tendon stem cells (TSCs) on tendon healing in a rat model. Patellar tendon TSCs were isolated and underwent transfection with lentiviral vectors containing HGF or green fluorescent protein (GFP) genes. In vivo, immunohistochemistry of tendons sampled 1 week postsurgery demonstrated that all stem cell-treated groups exhibited higher numbers of CD163+ M2 monocytes and IL-10+ cells (anti-inflammatory), and lower numbers of CCR7+ M1 monocytes and IL-6+ as well as COX-2+ cells (pro-inflammatory). Effects were most pronounced in the HGF-expressing TSCs (TSCs + HGF) treated group. Histology ± immunohistochemistry of tendons sampled 4 and 8 weeks postsurgery demonstrated that all stem cell-treated groups exhibited more ordered collagen fiber arrangement and lower levels of COLIII, α-SMA, TGF-ß1, and fibronectin (proteins relevant to fibroscarring). Effects were most pronounced in the TSCs + HGF-treated group. For the in vitro study, isolated tendon fibroblasts pretreated with TGF-ß1 to mimic the in vivo microenvironment of tendon injury were indirectly cocultured with TSCs, TSCs + GFP, or TSCs + HGF using a transwell system. Western blotting demonstrated that all stem cell types decreased TGF-ß1-induced increases in fibroblast levels of COX-2, COLIII, and α-SMA, concomitant with decreased activation of major TGF-ß1 signaling pathways (p38 MAPK, ERK1/2, but not Smad2/3). This effect was most pronounced for TSCs + HGF, which also decreased the TGF-ß1-induced increase in activation of the Smad2/3 signaling pathway. The presence of specific inhibitors of these pathways during fibroblast TGF-ß1 stimulation also attenuated increases in levels of COX-2, COLIII, and α-SMA. In conclusion, TSCs + HGF, which exhibit HGF overexpression, may promoting tendon healing via decreasing inflammation and fibrosis, perhaps partly via inhibiting TGF-ß1-induced signaling. These findings identify a novel potential therapeutic strategy for tendon injuries, warranting additional research.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China